胸腺癌的临床诊治进展  

Clinical diagnosis and treatment progress of thymic carcinoma

作　　者：邵名睿 李文雅[1] 贾心善[2] 

机构地区：[1]中国医科大学附属第一医院胸外科,辽宁沈阳110001 [2]中国医科大学附属第一医院病理科,辽宁沈阳110001

出　　处：《现代肿瘤医学》2016年第7期1158-1161,共4页Journal of Modern Oncology

基　　金：国家自然科学基金面上项目(编号:81370100);辽宁省自然科学基金资助项目(编号:2015020561);中国医科大学附属第一医院科学研究基金(编号:fsfh1514)

摘　　要：胸腺癌是发病率较低的胸腺上皮肿瘤,较为罕见,侵袭力强,恶性程度高,但临床表现缺乏特征性,术前诊断与恶性胸腺瘤鉴别困难。治疗多采取手术、放疗、化疗的综合治疗,完整切除是最有效的治疗手段,辅助治疗方案多样化,缺乏规范和共识。本文对近年来胸腺癌的分类、分期、分子特征以及临床诊治进展作一综述。Thymic carcinoma has a low attack rate. It is a rare,aggressive,and high malignant tumor. However,it is hard to distinguish thymic carcinoma and thymoma before surgery because of its lack of clinical feature. It usually takes the comprehensive treatments of surgery,radiotherapy and chemotherapy. Complete resection is the most useful treatment. There are diverse auxiliary treatments,but it lacks criterion and consensus. In this paper,we summarize the classification,stage,molecular character and progress in clinical diagnosis and treatment in recent years.

关 键 词：胸腺癌 治疗 预后 

分 类 号：R736.3[医药卫生—肿瘤]